Highlights Bio-Techne Corporation

Equities

TECH

US09073M1045

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-01 pm EDT			5-day change	1st Jan Change
73.46 ^USD	+16.22%		+15.65%	-4.80%

May. 01	Equity Markets Mostly Fall After Fed Leaves Rate Unchanged	MT
May. 01	Equity Markets Mostly Fall After Fed Leaves Rate Unchanged	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Equity Markets Mostly Fall After Fed Leaves Rate Unchanged	May. 01	MT
Top Midday Gainers	May. 01	MT
Bio-Techne Shares Jump After Fiscal Q3 Beat	May. 01	MT
Bio-Techne's Fiscal Q3 Adjusted Earnings Fall, Net Sales Rise	May. 01	MT
Earnings Flash (TECH) BIO-TECHNE CORPORATION Reports Q3 Revenue $303.4M	May. 01	MT
Bio-Techne Corporation Declares Dividend for the Quarter Ended March 31, 2024, Payable on May 24, 2024	May. 01	CI
Bio-Techne to Enter Product Distribution Deal With Thermo Fisher Scientific	Apr. 29	MT
Bio-Techne Corporation Announces New Distribution Agreement with Thermo Fisher Scientific	Apr. 29	CI
Bio-Techne Corporation and Novomol-Dx Announce Point-of-Care Ocular Biomarker Assay	Apr. 26	CI
Bio-Techne Says It Filed Patent Infringement Lawsuit Against Molecular Instruments in Europe	Apr. 23	MT
Bio-Techne Positioned for Growth Amid Biotech Funding Recovery, UBS Says	Mar. 28	MT
Bio-Techne Says European Union IVDR Certification Received for Diagnostic Test Tracking Chronic Myeloid Leukemia	Mar. 22	MT
Ex-dividend day	Feb. 08	FA
Bio-Techne Seeks M&A	Feb. 01	CI
Bio-Techne's Fiscal Q2 Adjusted Earnings Fall, Net Sales Rise	Feb. 01	MT
Earnings Flash (TECH) BIO-TECHNE CORPORATION Reports Q2 Revenue $272.6M, vs. Street Est of $277.7M	Feb. 01	MT
Bio-Techne Corporation Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	Feb. 01	CI
Bio-Techne Corporation Announces to Pay A Dividend for the Quarter Ended December 31, 2023, Payable February 26, 2024	Feb. 01	CI
North American Morning Briefing : Stock Futures -2-	Feb. 01	DJ
Bio-Techne Corporation Sets New Standard with the Development of A Next-Generation, Protease-Free RNAscope Spatial Multiomics Workflow	Jan. 29	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Bio-Techne Corporation

Equities

TECH

US09073M1045

Highlights

Filters